Mechanisms of neuronal loss in Parkinson's disease: a neuroanatomical-biochemical perspective
- 31 December 1992
- journal article
- review article
- Published by Elsevier in Clinical Neurology and Neurosurgery
- Vol. 94, 9-11
- https://doi.org/10.1016/0303-8467(92)90008-q
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkeyNeuroscience, 1991
- Symptomatic and asymptomatic 1 -methyl-4-phenyl-1,2,3,6-tetrahydropyridinetreated primates: Biochemical changes in striatal regionsNeuroscience, 1989
- 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and free radicals in vitroBiochemical Pharmacology, 1988
- The neurotoxin MPTP does not reproduce in the rhesus monkey the interregional pattern of striatal dopamine loss typical of human idiopathic Parkinson's diseaseNeuroscience Letters, 1988
- MPTP Effects on Dopamine NeuronsAnnals of the New York Academy of Sciences, 1988
- Uneven Pattern of Dopamine Loss in the Striatum of Patients with Idiopathic Parkinson's DiseaseNew England Journal of Medicine, 1988
- MPTPClinical Neuropharmacology, 1986
- The specific vulnerability of the substantia nigra to MPTP is related to the presence of transition metalsBiochemical and Biophysical Research Communications, 1985